300942 易瑞生物
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资143,019-1.49%145,179195,75821,9443,507
投资性房地产0--005,2505,387
固定资产55,025-3.64%57,10283,98652,62844,887
在建工程393,16610.25%356,626190,86751,3410
无形资产41,049-0.83%41,39342,40042,60044,124
商誉0--0000
其他非流动资产14,221-22.59%18,37095,02681,11328,852
646,4804.50%618,669608,036254,876126,757

流动资产
货币资金500,3513.86%481,749247,451342,211379,097
应收账款60,480-20.58%76,14883,87897,05262,300
存货34,97211.16%31,461100,60893,85961,590
其他流动资产153,8533.74%148,312242,482364,52223,143
749,6551.62%737,670674,419897,644526,129

流动负债
短期借款0--0000
应付票据0--0000
应付帐款78,5921.60%77,35265,10755,65814,644
其他流动负债52,309-12.20%59,575134,676100,96863,475
130,901-4.40%136,927199,784156,62678,119
流动资产净值618,7533.00%600,743474,636741,018448,010
资产总额减流动负债1,265,2333.76%1,219,4121,082,672995,894574,767

非流动负债
长期借款147,76947.28%100,32956,32000
应付债券250,3371.99%245,452000
其他非流动负债23,690-4.87%24,90361,65149,31425,784
421,79613.79%370,684117,97149,31425,784

总权益
    实收股本400,8650.00%400,860400,860400,860360,000
    储备项目440,993-1.59%448,134564,031543,903189,054
股东权益841,858-0.84%848,994964,891944,763549,054
非控股权益1,580-693.98%(266)(190)1,817(70)